Amphix Bio

Chicago, United States

Amphix Bio is a biotechnology company that develops regenerative medicine therapies using a platform of supramolecular therapeutic peptides.

$12.5M raised

Dec 2025

Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Amphix Bio raised?

Amphix Bio has raised $12.5M in total funding. The most recent round was Seed. The last funding was announced in December 2025.

Who are Amphix Bio's investors?

Amphix Bio's investors include National Science Foundation.

Where is Amphix Bio headquartered?

Amphix Bio is headquartered in Chicago, United States.

What does Amphix Bio do?

Amphix Bio is a biotechnology company that develops regenerative medicine therapies using a platform of supramolecular therapeutic peptides.

What stage is Amphix Bio at?

Amphix Bio is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 18, 2025.

MLA

"Amphix Bio — Funding & Investors." VCBacked, December 18, 2025, https://www.vcbacked.co/company/amphix-bio. Accessed July 2, 2026.

APA

VCBacked. (2025). Amphix Bio — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/amphix-bio

Wikipedia (cite web)

{{cite web |title=Amphix Bio — Funding & Investors |url=https://www.vcbacked.co/company/amphix-bio |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 18, 2025.